Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07214571
What this trial is testing

S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Who this might be right for
Respiratory Syncytial Virus Infections
Shionogi 192
Not applicableStudy completedNCT01922648
What this trial is testing

RSV Observational Study 2

Who this might be right for
Respiratory Syncytial Virus Infections
University of Oxford 35
Not applicableStudy completedNCT06482099
What this trial is testing

SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

Who this might be right for
Respiratory Tract Infection
Pfizer 497
Testing effectiveness (Phase 2)Looking for participantsNCT06817889
What this trial is testing

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT06573281
What this trial is testing

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 213
Not applicableStudy completedNCT02899065
What this trial is testing

Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

Who this might be right for
Influenza, Human
University of California, Davis 200
Large-scale testing (Phase 3)Looking for participantsNCT06775405
What this trial is testing

Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Who this might be right for
Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 180
Not applicableStudy completedNCT06424795
What this trial is testing

Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants

Who this might be right for
Respiratory Syncytial Virus Infection
University of Rochester 100
Not applicableStudy completedNCT03614676
What this trial is testing

Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 4,493
Testing effectiveness (Phase 2)Study completedNCT06143046
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 360
Testing effectiveness (Phase 2)UnknownNCT00696540
What this trial is testing

Hypertonic Saline for Outpatient Bronchiolitis

Who this might be right for
BronchiolitisRespiratory Distress
University Diego Portales 74
Not applicableUnknownNCT04925310
What this trial is testing

Infection With Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)Respiratory Syncytial Virus-bronchiolitis
Hannover Medical School 350
Not applicableUnknownNCT05765838
What this trial is testing

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

Who this might be right for
InfluenzaCOVID-19RSV Infection
Rigshospitalet, Denmark 250
Testing effectiveness (Phase 2)Study completedNCT04138056
What this trial is testing

A Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 509
Testing effectiveness (Phase 2)Study completedNCT05687279
What this trial is testing

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Who this might be right for
Respiratory Syncytial Virus Infection
Sanofi Pasteur, a Sanofi Company 80
Not applicableActive Not RecruitingNCT06640387
What this trial is testing

CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools

Who this might be right for
SARS CoV 2 InfectionRSV InfectionInfluenza+2 more
The Hospital for Sick Children 500
Not applicableStudy completedNCT01563692
What this trial is testing

Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers

Who this might be right for
Healthy
University of Oxford 30
Testing effectiveness (Phase 2)Looking for participantsNCT06665100
What this trial is testing

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Who this might be right for
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Pulmotect, Inc. 100
Not applicableUnknownNCT05928507
What this trial is testing

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Who this might be right for
Influenza AInfluenza Type BSARS CoV 2 Infection+1 more
Baebies, Inc. 2,500
Early research (Phase 1)UnknownNCT06313697
What this trial is testing

Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult

Who this might be right for
Respiratory Syncytial Virus Infections
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 132
Next Page